Phillip J. Gray, Jonathan J. Paly, Beow Y. Yeap, Martin G. Sanda, Howard. M. Sandler, Jeff M. Michalski, James A. Talcott, John J. Coen, Daniel A. Hamstra, William U. Shipley, Stephen M. Hahn, Anthony L. Zietman, Justin E. Bekelman and Jason A. Efstathiou Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer Cancer 119
Article first published online: 22 FEB 2013 | DOI: 10.1002/cncr.27956
Prostate cancer patients who receive 3-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy report distinct patterns of treatment-related quality of life. Although the timing of toxicity varies between cohorts, patients report similar modest quality-of-life decrements in the bowel domain and minimal QOL decrements in the urinary domains at 24 months.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field